Bone Marrow TransplantationTransplantation, AutologousBone MarrowTransplantation, HomologousBone Marrow CellsCombined Modality TherapyHematopoietic Stem Cell TransplantationGraft vs Host DiseaseBone Marrow PurgingWhole-Body IrradiationAntineoplastic Combined Chemotherapy ProtocolsTransplantation ConditioningBone and BonesCyclophosphamideLeukemiaGraft SurvivalLymphoma, Non-HodgkinHematopoietic Stem CellsBusulfanLiver TransplantationAnemia, AplasticTissue DonorsTreatment OutcomeCarmustineMelphalanStem Cell TransplantationRecurrenceKidney TransplantationRemission InductionTransplantation ChimeraLeukemia, Myeloid, AcuteHistocompatibility TestingMultiple MyelomaHematopoiesisBone Marrow DiseasesTime FactorsImmunosuppressive AgentsHodgkin DiseaseTransplantation, IsogeneicHematologic NeoplasmsHistocompatibilitySurvival AnalysisEtoposideColony-Forming Units AssayPrecursor Cell Lymphoblastic Leukemia-LymphomaGraft RejectionRetrospective StudiesImmunosuppressionCytarabineLeukemia, MyeloidLeukemia, Myelogenous, Chronic, BCR-ABL PositiveSalvage TherapyGranulocyte Colony-Stimulating FactorAntigens, CD34Disease-Free SurvivalHeart TransplantationBone Marrow ExaminationHematopoietic Stem Cell MobilizationSurvival RateFollow-Up StudiesMice, Inbred C57BLBone RemodelingCytomegalovirus InfectionsAcute DiseasePeripheral Blood Stem Cell TransplantationMyelodysplastic SyndromesCyclosporineRadiation ChimeraBone Marrow NeoplasmsHepatic Veno-Occlusive DiseaseActuarial AnalysisHematologic DiseasesLung TransplantationLymphomaT-LymphocytesTransplantation ImmunologyCell TransplantationHLA AntigensLymphocyte DepletionPrognosisGraft vs Host ReactionCell DifferentiationVincristineLeukocyte CountCells, CulturedCell SeparationBone DensityOrgan TransplantationThiotepaFlow CytometryProspective StudiesOpportunistic InfectionsAntibodies, MonoclonalGraft vs Tumor EffectImmunocompromised HostLeukocyte TransfusionChimeraLymphocyte TransfusionBone TransplantationTransplantation